![Craig Crews on “Induced Proximity: Exploring New Therapeutic Modalities” at ICR](https://oncodaily.com/pub/uploads/2024/09/download-26-e1725776958731-1280x721.png)
Craig Crews on “Induced Proximity: Exploring New Therapeutic Modalities” at ICR
The Institute of Cancer Research posted on LinkedIn:
“Earlier this week, we were delighted to welcome Professor Craig Crews, Executive Director of Yale Center for Molecular Discovery to ICR’s Sutton campus where he presented a guest lecture titled ‘Induced Proximity: Exploring New Therapeutic Modalities’
Professor Crews is a leading figure in the targeted protein degradation field, which ultimately inspired a broader concept of induced proximity in drug discovery.
He discussed his recent work from his lab developing RIPTACs, or Regulated Induced Proximity Targeting Chimeras.
We are grateful for Professor Crews’ visit and for sharing his valuable expertise with us.”
Source: The Institute of Cancer Research/LinkedIn
Craig M Crews, is the John C. Malone Professor of Molecular, Cellular, and Developmental Biology and Professor of Chemistry, of Pharmacology, and of Management at the Yale School of Medicine. He graduated from the U.Virginia with a B.A. in Chemistry and received his Ph.D. from Harvard University in Biochemistry.
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023